Back to Search
Start Over
177O Lenvatinib plus pembrolizumab versus treatment of physician’s choice in patients with previously treated advanced endometrial cancer: Study 309/KEYNOTE-775 Asian subgroup
- Source :
- Annals of Oncology. 33:S1504-S1505
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Oncology
Hematology
Subjects
Details
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........d2597613ea2ead4ce9b57138a8e42ba6
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.10.213